Gerber Soothe® Probiotic Colic Drops 

for babies when colic, excessive crying and fussiness, and frequent spit-ups appear

L. reuteri  is the only probiotic, clinically shown to be effective for reducing colic and spit-ups*
Soothe_Probiotic_Colic_Drops

Probiotic L. reuteri :

Only probiotic clinically shown to be effective for reducing colic and spit-ups*

  • Clinically shown to significantly reduce crying time in as little as 1 week*
  • Reduces frequency of spit-ups by 50% in as little as two weeks*

Promotes regular stools and abdominal comfort*

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
In the dietary supplement colic category. Based on a QuintilesIMS ProVoice Survey (2019).

Gerber Soothe® Probiotic Colic Drop

YOUR PATIENTS CAN RECEIVE A $5 SAVINGS§ + FREE SHIPPING by using promo code COMFORT at checkout – ONLY at TheGerberStore.com

§Restrictions may apply.

Studies

L. reuteri significantly reduced crying time by 50% in as little as one week

Graph

L. reuteri reduced crying time from >6 hours to ~1.5 hours/day in as little as one week

Adapted from Savino et al, 20101

Study design: Randomized, placebo-controlled, double-blind study of exclusively breastfed, colicky infants. Infants were randomly assigned to receive 1x108 CFU/day of L. reuteri or placebo. The objective of this study was to test the efficacy of L. reuteri on colic as measured by crying. In addition, the intestinal microflora was analyzed to determine the effect of the probiotic on selected intestinal microbiota (E.coli, Clostridium butyricum, Lactobacillus, and Bifidobacterium).

divider

L. reuteri reduces frequency of spit-ups by 50% in as little as 2 weeks

Graph
Adapted from Garofoli et al, 20142
*In healthy newborn breastfed infants.

Study design: 40 breastfed full-term infants were randomly, double-blind assigned to receive orally L. reuteri DSM 17983, 5 drops/daily (1x108 CFU), for 4 weeks (n=20) or an identical placebo (control, n=20), starting before third day of life. Growth parameters and gastrointestinal diseases were monitored in those 1 month old infants. Parents registered daily numbers of regurgitations, as well as crying minutes, stool frequency and consistency, and adverse events.

References: 1. Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatr. 2010;126(3):e526-33. 2. Garofoli F, Civardi E, Indrio F, et al. The early administration of Lactobacillus reuteri DSM 17938 controls regurgitation episodes in full-term breastfed infants. Int J Food Sci Nutr. 2014;65(5):646-648.
scroll to top